Clinical Trial Update: Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial of OncoSorb for advanced cancer entities (Phase 1/Phase 2) sponsored by BioPheresis GmbH has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• OncoSorb

Snippet

Sponsor: BioPheresis GmbH | Conditions: Advanced Cancer Entities | Phase 1, Phase 2 | Status: TERMINATED